Evidence map

ArticleLiver research (Beijing, China)2025

Resmetirom and beyond: A new era in MASLD therapeutics.

Tejona Johnson-Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41602128